Intelligent dentistry: AI is making surgeries safer The AIPLANT project aims to reduce complications from dental implant surgery using AI-based preoperative planning. The project is a collaboration […] October 17, 2023 · MEDVIA
Health data standardization: What FHIR can do for you! Patient data is a treasure trove of information, vital to tailoring individual care pathways and generating profound insights to enhance […] October 17, 2023 · Janssen Pharmaceutica
V-Bio Ventures portfolio company Agomab raises $100 million Series C to advance fibrosis-focused pipeline — Round led by Fidelity Management & Research Company with participation from new investors EQT Life Sciences, Canaan and Dawn […] October 11, 2023 · V-Bio Ventures
Belgium needs boldness for healthcare innovation This year, Science for health will explore the inspiring innovations at the interface of biology and technology. The event will […] September 27, 2023 · Janssen Pharmaceutica
Lean years for company creation in Europe? After an exceptional sequence of socio-economic shocks over the past few years, the number of new companies being formed in […] September 27, 2023 · V-Bio Ventures
Pharmaceutical market access: how real-world data fuel better health beyond clinical trials Studies of a drug’s effectiveness and safety don’t end with clinical trials – they extend beyond market access when the […] September 27, 2023 · Janssen Pharmaceutica
Hearts in space: a Belgian story of successful collaboration AstroCardia has developed a heart-on-a-chip to study cardiovascular aging… in space! Trials will begin in 2025 aboard the International Space […] September 26, 2023 · MEDVIA
V-Bio Ventures portfolio company Orionis Biosciences announces collaboration with Genentech to discover and develop molecular glue class medicines September 20, 2023, BOSTON, MA and GHENT, Belgium – Orionis Biosciences, a privately held life sciences company with an integrated […] September 20, 2023 · V-Bio Ventures
Augustine Therapeutics expands its leadership team and R&D platform, enters regulatory development. Leuven, Belgium, September 12th, 2023 – Augustine Therapeutics, a biotech company developing innovative therapies for neuromuscular and neurodegenerative disorders, announced […] September 12, 2023 · Press Release
V-Bio Ventures portfolio company Corteria Pharmaceuticals raises EUR 65 million to advance its transformational medicines for cardiovascular diseases Ghent, Belgium, 7 September 2023 – Corteria Pharmaceuticals, a V-Bio Ventures portfolio company, is a biopharmaceutical company specialized in the […] September 7, 2023 · V-Bio Ventures
Jan Rabaey on the convergence of biology and technology Belgian Prof. Jan Rabaey has spent the past 35 years conducting pioneering tech research at the University of California at […] August 23, 2023 · Janssen Pharmaceutica
Johan Cardoen’s hopes for the future of agriculture Flanders is home to one of the world’s most innovative agrifood clusters, and Johan Cardoen has been a central figure […] August 23, 2023 · BioVox
Fermenting a more sustainable future In the battle against the climate crisis, precision fermentation presents a hopeful aid. Using microbes to create valuable materials, we […] August 23, 2023 · V-Bio Ventures
Biodevice-CRO: smart solutions for better bioprocessing Biodevice-CRO is a MEDVIA project uniting three very different, but complementary, Flemish companies: ICsense, Comate, and Antleron. This unique partnership […] August 23, 2023 · MEDVIA
Bar.on presents the world’s first beer printer Instantly turning water into beer may sound like a biblical miracle, but that’s exactly what Belgian start-up Bar.on is now […] June 21, 2023 · BioVox